Concepedia

Kelly Treonze

KT

Statistics

Publications

2

Citations

77

H-Index

2

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kelly Treonze is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacy.

Publications per year

2009–2011

2

Publications

2

The fibrinogen cleavage product A -Val360, a specific marker of neutrophil elastase activity in vivo

Richard I. Carter, Richard A. Mumford, Kelly Treonze et al. · Thorax · 2011 · 66 citations · Full text

, , +17

Discovery of <i>N</i>-{<i>N</i>-[(3-Cyanophenyl)sulfonyl]-4(<i>R</i>)-cyclobutylamino-(<scp>l</scp>)-prolyl}-4-[(3′,5′-dichloroisonicotinoyl)amino]-(<scp>l</scp>)-phenylalanine (MK-0668), an Extremely Potent and Orally Active Antagonist of Very Late Antigen-4

Linus S. Lin, Thomas J. Lanza, James P. Jewell et al. · Journal of Medicinal Chemistry · 2009 · 11 citations · Full text

, , +17

1–2 of 2